RELX PLC: Stock Analysis and Future Predictions

Aug.26.2022
RELX PLC: Stock Analysis and Future Predictions
RELX stock falls slightly to $28.04, with average trading volume of 891,300 shares. Analysts rate it a "buy".

RELX PLC, trading on the New York Stock Exchange as RELX, closed at $28.04 on Wednesday with no change from the previous day's closing price. The average trading volume over the past five days was 891,300 shares. The stock price decreased by $0.82 in the past week, although it has reached a 17-fold high in the last 12 months. The average trading volume over the past 20 days was 660,680 shares, while the 50-day average trading volume was 1,016,512 shares.

 

Last month, shares of RELX fell by 0.85%. The company's stock reached its lowest point of $27.84 per share on August 23, 22. After rebounding to a 52-week high of $32.71 on January 3, the stock hit a low of $24.81 within the 52-week period. So far this year, the stock has reached a new high but has since dropped by 14.01% or $4.57. Despite this, the price is still down 14.28% from its 52-week high.

 

Valuation Metrics

 

The trailing P/E ratio for RELX PLC (RELX) is 29.06. Its beta is 0.74. Other valuation ratios to consider include a P/S ratio of 5.84, a PB ratio of 12.41, and a price-to-cash-flow ratio of 42.80.

 

The company's payout ratio stands at 52.60%. The latest quarterly dividend paid by the company was $0.4443 per share, which reflects a decline of 7.82% compared to the previous year's $0.4820 per share. The most recent dividend decrease of $0.0377 per share was announced on Friday, July 29, 2022.

 

Financial Health

 

Recently, the quick ratio of RELX PLC for the quarter was 0.50 and the current ratio is also 0.50, indicating that the company may not be able to fulfill its debts. Additionally, the company's long-term debt to equity ratio for the recent quarter was 1.63, and the total debt to equity ratio was 1.89. RELX PLC's EBITDA profit margin was 35.31%, while the operating profit margin for the same period was 27.10%. It has been reported that the company's total profit is $6.44 billion and its revenue is $9.96 billion.

 

Profit Surprises

 

The company had a net income of 1.47 billion USD for this quarter, with a revenue growth of 16.79%.

 

From a technical analysis perspective, let's take a brief look at the price trends of RELX PLC (RELX). As of the close on August 24th, the 9-day RSI was 31.06%, indicating the stock is neutral, and the historical volatility during this timeframe was 10.78%.

 

As of today, the price of RELX is $28.49, a decrease of 2.84% compared to its five-day moving average of $0.82. RELX's current trading price is 2.37% lower than its 20-day simple moving average and 9.84% lower than its 100-day SMA. However, its current price is higher than its 50-day SMA by 7.72% but lower than its 200-day SMA by 11.60%.

 

The random values for K and D are 8.36% and 10.25% respectively, with an average true range (ATR) of 0.36. Over a 14-day period, the random value is 11.30% with an average true range of 0.38, while the RSI (14) is 41.09%. The stock's 9-day MACD oscillator has reached -0.46, while the reading for 14 days is -0.59.

 

Analyst rating.

 

Kepler has upgraded RELX PLC (NYSE code: RELX) to a buy rating in its latest analyst report. Previously, the stock was rated as hold. The consensus rating for RELX PLC (RELX) among analysts is overweight. According to current broker recommendations, zero brokerage firms suggest selling RELX while two suggest holding. There are no analysts who rate the stock as underweight. The stock is rated as overweight by zero analysts while one other analyst rates it as a buy.

 

What is RELX's price target for the next 12 months?

 

Analysts predict a target price range of $32.80 to $32.80, with a median target of $32.80 for RELX PLC (RELX) stock. Based on these predictions, the average target price given by analysts is $32.80.

 

 


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Product | HQD SiSA 80K Enters the U.S. Market With a Hookah-Inspired Approach to the High-Capacity Disposable Segment
Product | HQD SiSA 80K Enters the U.S. Market With a Hookah-Inspired Approach to the High-Capacity Disposable Segment
The HQD SiSA 80K Hookah Disposable Vape has appeared across U.S. and cross-border online retail channels. The device comes prefilled with 28ml of e-liquid, uses a 5% nicotine salt configuration and carries a brand claim of up to 80,000 puffs. Beyond puff count, the product differentiates itself through hookah-inspired features including adjustable airflow, a flowing-water sound effect and flavor options associated with traditional hookah consumption.
Aug.18
Ireland’s Vape Tax Raises €22 Million in Nine Months as Government Considers 2027 Budget Changes
Ireland’s Vape Tax Raises €22 Million in Nine Months as Government Considers 2027 Budget Changes
According to Irish media outlets Highland Radio and BreakingNews.ie, the Irish government is considering whether to adjust vape tax policy in the 2027 Budget. The tax has generated about €22 million ($24 million) in revenue during its first nine months. While no increase has been confirmed, the revenue performance could influence future fiscal discussions. Any tax rise could increase product costs and potentially affect retail prices.
Aug.12
JAMA Issues First U.S. Clinical Guidance on Vaping for Smoking Cessation, Urging Complete Switch From Cigarettes
JAMA Issues First U.S. Clinical Guidance on Vaping for Smoking Cessation, Urging Complete Switch From Cigarettes
JAMA has published a Special Communication offering systematic recommendations for U.S.-based clinicians on the use of nicotine e-cigarettes in adult smoking cessation. Developed by the Harm Reduction Workgroup of the Society for Research on Nicotine and Tobacco’s Treatment Research Network, the paper recommends including e-cigarettes alongside FDA-approved cessation medications in risk-benefit discussions. It cites high-certainty evidence that nicotine e-cigarettes achieve higher quit rates than nicotine replacement therapy and evidence suggesting efficacy comparable to highly effective medications such as varenicline and cytisine. For adults who choose vaping to quit, the authors recommend FDA-authorized products, sufficient nicotine delivery and a rapid, complete transition away from cigarettes rather than prolonged dual use.
Aug.13
UK PM Andy Burnham Shifts Business Rates Policy, Supporting Hospitality While Raising Pressure on Vape Shops
UK PM Andy Burnham Shifts Business Rates Policy, Supporting Hospitality While Raising Pressure on Vape Shops
UK Prime Minister Andy Burnham’s government is adjusting business rates policy to support hospitality businesses while some other sectors, including vape retailers, face higher operating cost pressures. According to Streamline Feed, AJ Bell and other reports, the policy shift reflects a redistribution of business rate burdens as the government seeks to support sectors facing economic pressure. For UK vape shops, the change comes amid a broader regulatory environment shaped by the disposable vape ban, the upcoming Vaping Products Duty and increased compliance requirements.
News
Jul.24
Data|China’s May Vape Exports Fall 10.3%; January–May Shipments Slip 0.9%
Data|China’s May Vape Exports Fall 10.3%; January–May Shipments Slip 0.9%
China’s vape-related exports fell 10.25% year on year in May 2026, marking a second consecutive monthly decline, although exports recovered modestly from April. January-May exports totaled US$4.018 billion, down 0.86% from a year earlier and broadly in line with 2025 levels.
Special Report
Jun.29
Virginia Tightens Vape and Tobacco Retail Enforcement, With Fines Up to $15,000 Per Unlisted Product
Virginia Tightens Vape and Tobacco Retail Enforcement, With Fines Up to $15,000 Per Unlisted Product
A new Virginia law that took effect on July 1, 2026, requires retailers to obtain permits to sell liquid nicotine, vape and tobacco products, while directing Virginia ABC to conduct inspections and verify that stores sell only products listed in the state directory.
Jul.20